Angiotensin II improves random-flap viability in a rat model

Annals of Plastic Surgery

Volumn 42, Issue 3, 1999, Pages 313-319

  Okuyama, Naoki ^d   Roda, Norma ^a   Sherman, Randy ^b   Guerrero, Abraham ^a   Dougherty, William ^b   Nguyen, Thuan ^b   DiZerega, Gere ^a   Rodgers, Kathleen ^a,c  

^a ROSS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Livingston Research Center   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN;

ANGIOGENESIS; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN FLAP;

EID: 0033016277     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000637-199903000-00014     Document Type: Article

References (65)

1. McGregor IA, McGregor AD. Flaps. In: Fundamental techniques of plastic surgery and their surgical applications. 9th ed. London: Churchill Livingston. 1991:61-119
2. Kayser MR, Hodges PL. Principles of flaps. Select Read Plast Surg 1995;8(3):1-58
3. Grotendorst GR. Martin GR. Pencev D, et al. Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. J Clin Invest 1988;76: 2323-2329
4. Mustoe TA, Pierce GF, Thomason A, et al. Accelerated healing of incisional wounds in rats induced by transforming growth factor-ß. Science 1989;237:1333-1335
5. Pierce GF, Mustoe TA, Senior RM, et al. In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins. J Exp Med 1989;167:974-987
6. Brown GL, Curtsinger LJ, White M, et al. Acceleration of tensile strength of incisions treated with EGF and TGF-β. Ann Surg 1989;208:788-794
7. McGee GS, Broadley KN, Buckley A, et al. Recombinant transforming growth factor beta accelerates incisional wound healing. Curr Surg 1989;46:103-105
8. Lynch SE, Colvin RB, Antoniades NH. Growth factors in wound healing. J Clin Invest 1989;84:640-646
9. Fiddes JC, Hebda PA, Robson MC, et al. Preclinical wound healing studies with recombinant human basic fibroblast growth factor. Ann N Y Acad Sci 1991;368:316-328
10. Robson MC, Phillips LG, Thomason A, et al. Platelet-derived growth factor-BB for the treatment of chronic pressure ulcers. Lancet 1992;339:23-26
11. Robson MC, Phillips LG, Lawrence WT, et al. The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores. Ann Surg 1992;216:401-408
12. Robson MC. Growth factors as wound healing agents. Curr Opin Biotech 1991;2:863-867
13. Medhi K, Juhn SK, Assefa G, et al. Vascular effects of sustained release fibroblast growth factors. Ann Otol Rhinol Laryngol 1996;105:109-116
14. Stepnick DW, Peterson MK, Bodgan C, et al. Effects of tumor necrosis factor on neovascularization of the rabbit ear flap. Arch Otolaryngol Head Neck Surg 1995;121:667-672
15. Nall AV, Brownlee RE, Colvin CP, et al. Transforming growth factor bl improves wound healing and random flap survival in normal and irradiated rats. Arch Otolaryngol Head Neck Surg 1996;122:171-177
16. Kawahara Y, Sunako M, Tsuda T, et al. Angiotensin II induces expression of the c-fos gene through protein kinase C activation and calcium ion mobilization in cultured vascular smooth muscle cells. Biochem Biophys Res Commun 1988;150:52-59
17. Dzau VE, Pratt R, Gibbons G, et al. Molecular mechanism of angiotensin in the regulation of vascular and cardiac growth. J Mol Cell Cardiol 1988;21(Suppl III):S7 [abstract]
18. Berk BC, Vekshtein V, Gordon HM, et al. Angiotensin II stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 1988;13:305-314
19. Naftilan AJ, Pratt RE, Dzau VJ. Induction of plateletderived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1419-1424
20. 2+ mobilization and protein kinase C activation. J Biol Chem 1989;264:526-530
21. Bell L, Madri JA. Influence of the angiotensin system on endothelial and smooth muscle cell migration. Am J Pathol 1990;137:7-12
22. Nakahara K, Nishimura H, Kuroo M, et al. Identification of three types of PDGF-A chain gene transcripts in rabbit vascular smooth muscle and their regulated expression during development and by angiotensin II. Biochem Biophys Res Commun 1992;184:811-818
23. Stouffer GA, Owens GK. Angiotensin II induced mitogenesis of spontaneously hypertensive rat derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-β. Circ Res 1992; 70:820
24. Wolf G, Haberstroh U, Neilson EG. Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 1992;140: 95-107
25. Fernandez LA, Twickler J, Mead A. Neovascularization produced by angiotensin II. J Lab Clin Med 1985;105: 141-144
26. LeNoble FAC, Hekking JWM, Van Staaten HWM. et al. Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur J Pharmacol 1991;195:305-306
27. Rodgers KE, Abiko M, Girgis W, et al. Acceleration of dermal tissue repair by angiotensin II. Wound Rep Regen 1997;5:175-183
28. Rodgers KE, DeCherney AH, Amand KM, et al. Histologic alterations in dermal repair after thermal injury: effects of angiotensin II. J Burn Care Rehabil 1997;18:381-388
29. McFarlane RM, DeYoung G, Henry RA. et al. The design of a pedicle flap in the rat to study necrosis and its prevention. Plast Reconstr Surg 1965;35:177-182
30. Waters LM. Pearl RM, Macaulay RM. A comparative analysis of the ability of five classes of pharmacological agents to augment skin flap survival in various models and species: an attempt to standardize skin flap research. Ann Plast Surg 1989;23:117-122
31. Hjortdal VE, Sinclair T, Kerrigan CL, et al. Arterial ischemia in skin flaps: microcirculatory intravascular thrombosis. Plast Reconstr Surg 1989;93:375-385
32. Hjortdal VE. Sinclair T, Kerrigan CL, et al. Venous ischemia in skin flaps: microcirculatory intravascular thrombosis. Plast Reconstr Surg 1995;93:366-374
33. Phillips MI. Kimura B, Krim AJ, et al. Angiotensin II (Ang II) in skin may act as a growth factor and enhance wound healing. FASEB J 1991;5:A904. Abstract no. 3103
34. Tsutsumi K, Stromberg C, Viswanathan M. et al. Angiotensin II receptor subtypes in fetal tissues in the rat: autoradiography. guanine nucleotide sensitivity, and association with phosphoinositide hydrolysis. Endocrinology 1991;129:1075-1082
35. Fossum GT. Phillips MI. Konicek JR. Angiotensin II (All) may have an initial and localized role in wound healing. Soc Gynecol Invest 1991;21:Abstract no. 204
36. Viswanathan M, Saavedra JM. Expression of angiotensin II AT, receptors in rat skin during experimental wound healing. Peptides 1991;13:783-786
37. Kimura B, Sumners C, Phillips MI. Changes in skin angiotensin II receptors in rats during wound healing. Biochem Biophys Res Commun 1992;187:1083-1090
38. Viswanathan M, Tsutsumi K, Correa FMA. et al. Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem Biophys Res Commun 1991;179:1361-1367
39. Janiak P, Pillon A, Prost JF, et al. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension 1992;20:737-745
40. Phillips MI, Kimura B, Gyurko R. Angiotensin receptor stimulation of transforming growth factor-β in rat skin and wound healing. In: Saavedra JM. Timmermans PBMWM, eds. Angiotensin receptors. New York: Plenum Press. 1994:377-396
41. Abiko M, Rodgers KE, Campeau JD. et al. Alterations in angiotensin II receptor levels in full-thickness excisional wounds in rat skin. Wound Rep Regen 1997;5:175-183
42. Abiko M, Rodgers KE, Campeau JD, et al. Alterations in angiotensin II receptor levels in sutured wounds in rat skin. J Invest Surg 1996;9:447-453
43. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest 1992;90:456-461
44. Naftilan AJ. The role of angiotensin II in vascular smooth muscle cell growth. J Cardiovasc Pharmacol 1992;20:S37-S40
45. Zhou G, Brilla CG, Weber KT. Angiotensin II mediated stimulation of collagen synthesis in cultured cardiac fibroblasts. FASEB J 1992;6:A1914 [abstract]
46. Ketteler M, Noble NA, Border WA. Transforming growth factor-beta and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis? Annu Rev Physiol 1995;57:279-295
47. Kagami S, Border WA, Miller DE, et al. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 1994;93(6): 2431-2437
48. Koibuchi Y, Lee WS, Gibbons GH, et al. Role of transforming growth factor β-1 in the cellular growth response to angiotensin II. Hypertension 1993;21:1046-1050
49. Ito H, Mukoyama M, Pratt RE, et al. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 1993;91: 2268-2274
50. Greenhalgh DG, Sprugel KH, Murray MJ, et al. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 1990;136:1235-1246
51. Pierce GF, Tarpley JE, Yanagihara D, et al. Platelet-derived growth factor (BB homodimer). transforming growth factor-β1, and basic fibroblast growth factor in dermal wound healing. Am J Pathol 1992;140:1375-1388
52. Hefti F, Hosang M, Baumgartner HR. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186-188
53. Powell JS, Muller RKM. Rouge M, et al. The proliferative response to vascular injury is suppressed by converting enzyme inhibition. J Cardiovasc Pharmacol 1991; 16(Suppl 4):S42-S49
54. CapronL, Heudes D, Chajara A. et al. Effect of ramipril. an inhibitor of angiotensin converting enzyme, on the response of rat thoracic aorta to injury with a balloon catheter. J Cardiovasc Pharmacol 1991;18:207-211
55. Osterriedes W, Muller RKM, Powell JS, et al. Role of angiotensin II injury-induced neointima formation in rats. Hypertension 1991;18(Suppl II):60-64
56. Daemen MJAP, Lombardi DM, Bosnian FT, et al. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991;68: 450-456
57. Schelling P, Ganten D, Speck G. et al. Effects of angiotensin II and angiotensin II antagonist saralysin on cell growth and renin in 3T3 and SV3T3 cells. J Cell Physiol 1979;98:503-513
58. Campbell-Boswell M, Robertson AL. Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp Mol Pathol 1981;35:265-276
59. Emmett N, Archibold E, Harris-Hooker S. et al. Effect of saralasin (angiotensin II antagonist) on 3T3 cell growth and proliferation. J Cell Biol 1986;103:171. Abstract
60. Paquet JL, Bandonim-Legros M, Brunelle G, et al. Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats. J Hypertens 1986;8:565-572
61. Geisterfer AAT, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 1988;62:749-756
62. Temizer DH, Yoshizumi M, Perrella MA, et al. Induction of heparin-binding epidermal growth factor-like growth factor by phorbol ester and angiotensin II in rat aortic smooth muscle cells. J Biol Chem 1992;267:24892-24896
63. Bell L, Luthringer DJ, Madri JA, et al. Autocrine angiotensin system regulation of bovine aortic endothelial cell migration and plasminogen activator involves modulation of proto-oncogene pp60c-src expression. I Clin Invest 1992;89:315-320
64. Berk BC, Rao GN. Angiotensin Il-induced vascular smooth muscle cell hypertrophy: PDGF A-chain mediates the increase in size. J Cell Physiol 1992;154:368-380
65. Wolf G, Killen PD, Neilson EG. Intracellular signalling of transcription and secretion of type IV collagen after angiotensin II-induced cellular hypertrophy in cultured proximal tubular cells. Cell Reg 1991;2:219-227